NCT00564447

Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers

A Single-Center, Open-Label, Randomized Study of the Pharmacokinetics of AzaSite Ophthalmic Solution Versus Vigamox in the Conjunctiva of Healthy Volunteers Following a Single Ocular Administration

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Merck Sharp & Dohme LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the drug concentrations of AzaSite™ compared to Vigamox at various time points in conjunctiva tissue of healthy volunteers

Conditions

• Bacterial Infections
• Eye Infections

Interventions

Type	Name	Description
DRUG	Azithromycin	azithromycin topical solution 1% given as a single drop in a single eye
DRUG	Moxifloxacin	Moxifloxacin topical solution given as a single drop in a single eye

Timeline

• Start date: 2007-12-01
• Primary completion: 2007-12-01
• First posted: 2007-11-28
• Last updated: 2011-09-22
• Results posted: 2011-07-26